Alex Dobbin | Head of IR |
Rick Winningham | CEO |
Renee Gala | CFO |
Brett Haumann | Chief Medical Officer |
Jeffrey Borges | Leerink |
Tyler Van Buren | Piper Jaffray |
Jennifer Kim | Cantor Fitzgerald |
Brian Skorney | Baird |
Joseph Stringer | Needham |
Ladies and gentlemen, good afternoon. At this time, I’d like to welcome everyone to the Theravance Biopharma Conference Call. [Operator Instructions] Today's conference call is being recorded. And now I would like to turn the call over to Alex Dobbin, Head of Investor Relations. Please go ahead.